OPK Valuation

OPKO Health Inc

Add to Watchlist

Advanced Chart

1.320

+0.07(5.600%)1D

Overview
Forecast
Valuation
Earnings

OPK Relative Valuation

OPK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OPK is overvalued; if below, it's undervalued.

Historical Valuation

OPKO Health Inc (OPK) is now in the Fair zone, suggesting that its current forward PS ratio of 1.60 is considered Fairly compared with the five-year average of 85.56. The fair price of OPKO Health Inc (OPK) is between 1.10 to 1.59 according to relative valuation methord.

Relative Value

Fair Zone

1.10-1.59

Current Price：1.25

Fair

-6.10

Trailing

Forward

-13.29

EV/EBITDA

OPKO Health Inc. (OPK) has a current EV/EBITDA of -13.29. The 5-year average EV/EBITDA is -18.06. The thresholds are as follows: Strongly Undervalued below -94.63, Undervalued between -94.63 and -56.35, Fairly Valued between 20.22 and -56.35, Overvalued between 20.22 and 58.51, and Strongly Overvalued above 58.51. The current Forward EV/EBITDA of -13.29 falls within the Historic Trend Line -Fairly Valued range.

-6.91

EV/EBIT

OPKO Health Inc. (OPK) has a current EV/EBIT of -6.91. The 5-year average EV/EBIT is 0.43. The thresholds are as follows: Strongly Undervalued below -94.87, Undervalued between -94.87 and -47.22, Fairly Valued between 48.08 and -47.22, Overvalued between 48.08 and 95.72, and Strongly Overvalued above 95.72. The current Forward EV/EBIT of -6.91 falls within the Historic Trend Line -Fairly Valued range.

1.60

OPKO Health Inc. (OPK) has a current PS of 1.60. The 5-year average PS is 1.70. The thresholds are as follows: Strongly Undervalued below 0.92, Undervalued between 0.92 and 1.31, Fairly Valued between 2.09 and 1.31, Overvalued between 2.09 and 2.48, and Strongly Overvalued above 2.48. The current Forward PS of 1.60 falls within the Historic Trend Line -Fairly Valued range.

-9.43

P/OCF

OPKO Health Inc. (OPK) has a current P/OCF of -9.43. The 5-year average P/OCF is 5.51. The thresholds are as follows: Strongly Undervalued below -78.42, Undervalued between -78.42 and -36.46, Fairly Valued between 47.48 and -36.46, Overvalued between 47.48 and 89.44, and Strongly Overvalued above 89.44. The current Forward P/OCF of -9.43 falls within the Historic Trend Line -Fairly Valued range.

-16.89

P/FCF

OPKO Health Inc. (OPK) has a current P/FCF of -16.89. The 5-year average P/FCF is 1.18. The thresholds are as follows: Strongly Undervalued below -110.18, Undervalued between -110.18 and -54.50, Fairly Valued between 56.85 and -54.50, Overvalued between 56.85 and 112.53, and Strongly Overvalued above 112.53. The current Forward P/FCF of -16.89 falls within the Historic Trend Line -Fairly Valued range.

OPKO Health Inc (OPK) has a current Price-to-Book (P/B) ratio of 0.75. Compared to its 3-year average P/B ratio of 0.75 , the current P/B ratio is approximately 0.05% higher. Relative to its 5-year average P/B ratio of 1.07, the current P/B ratio is about -29.67% higher. OPKO Health Inc (OPK) has a Forward Free Cash Flow (FCF) yield of approximately -26.56%. Compared to its 3-year average FCF yield of -10.45%, the current FCF yield is approximately 154.20% lower. Relative to its 5-year average FCF yield of -6.23% , the current FCF yield is about 326.01% lower.

0.75

P/B

Median3y

0.75

Median5y

1.07

-26.56

FCF Yield

Median3y

-10.45

Median5y

-6.23

Competitors Valuation Multiple

The average P/S ratio for OPK's competitors is 1.46, providing a benchmark for relative valuation. OPKO Health Inc Corp (OPK) exhibits a P/S ratio of 1.60, which is 9.73% above the industry average. Given its robust revenue growth of -13.93%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Pediatrix Medical Group Inc

Ginkgo Bioworks Holdings Inc

4.05

-81.37%

690.69M

Performance Decomposition

Market capitalization of OPK decreased by 25.60% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -5.66 to -94.66.

The secondary factor is the Revenue Growth, contributed -13.93%to the performance.

Overall, the performance of OPK in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-13.93%

182.19M → 156.81M

Revenue Growth

1572.44%

-5.66 → -94.66

Margin Expansion

-1584.11%

0.33 → -4.89

P/E Change

-25.60%